NDRG4 has been shown to act via signaling pathways such as cyclin-D1, p27, XIAP, and survivin to increase tumor growth and inhibit apoptosis in other types of cancer [23], but no information on NDRG4 signaling pathways has been reported in breast cancer. Here, NDRG4 is linked to neoplasm.